Curcumin enhanced the degradation of EGFR protein, thereby suppressing its activation. This, in turn, resulted in the reversal of gefitinib in non-small cell lung cancer in both in vitro and in vivo conditions. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.